Welcome to our dedicated page for Silicon Labs SEC filings (Ticker: SLAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Silicon Laboratories Inc. (Silicon Labs, NASDAQ: SLAB) SEC filings, offering investors and analysts a primary view into the company’s regulatory disclosures. As a public semiconductor company focused on low-power wireless connectivity and embedded technology, Silicon Labs uses filings such as Forms 10-K, 10-Q, and 8-K to report its financial condition, risk factors, and material events.
In recent Form 8-K filings, Silicon Labs has reported quarterly results and explained its use of non-GAAP financial measures alongside GAAP metrics. These disclosures describe how the company adjusts for items like stock compensation expense, intangible asset amortization, acquisition- and disposition-related items, termination costs and impairments, equity-method investment adjustments, certain interest expense items, and income tax adjustments based on a long-term non-GAAP tax rate. The reconciliations included in these filings help readers understand the relationship between GAAP and non-GAAP results.
Through this SEC filings page, users can review annual reports (Form 10-K) for comprehensive discussions of Silicon Labs’ business, markets, and risks, and quarterly reports (Form 10-Q) for interim financial updates. Current reports (Form 8-K) provide timely information on earnings releases and other material developments. Where applicable, insider transaction reports (Form 4) can be used to track equity transactions by directors and officers.
Stock Titan enhances access to these documents with AI-powered summaries that highlight key sections, explain complex accounting or tax adjustments, and surface important changes across reporting periods. Real-time updates from EDGAR ensure that new Silicon Labs filings appear promptly, helping users quickly locate the information most relevant to their analysis of SLAB stock and the company’s financial reporting practices.
FMR LLC filed an amendment to a Schedule 13G reporting beneficial ownership of 697,454.83 shares, representing 2.1% of Silicon Laboratories Inc. common stock. The filing lists sole dispositive power of 697,454.83 shares and indicates ownership of 5% or less of the class. Signatures show authorization by Stephanie J. Brown on behalf of FMR LLC and Abigail P. Johnson, dated 03/05/2026.
Silicon Laboratories’ Chief Accounting Officer Mark D. Mauldin reported routine equity compensation changes. On February 15, 2026, he acquired 3,153 restricted stock units (RSUs) at $0 per share, which will vest in three equal annual installments under the company’s 2009 Stock Incentive Plan.
On February 13, 2026, 356 shares of common stock at $207.27 per share were disposed of to cover taxes upon vesting of a prior award. Following these transactions, he directly beneficially owned 21,930 shares of Silicon Laboratories common stock.
Silicon Laboratories Inc. executive Brandon Tolany reported an equity award of 8,669 shares of common stock. The Form 4 shows a grant coded as an acquisition at a price of $0 per share, increasing his directly held stake to 71,050 common shares.
The award is in the form of restricted stock units (RSUs), with each RSU convertible into one share of common stock. One-third of the RSUs will vest on each of the first three anniversaries of the February 15, 2026 grant date under the company’s 2009 Stock Incentive Plan.
Silicon Laboratories senior vice president and general manager Robert J. Conrad received an equity grant in the form of 8,669 shares of common stock on February 15, 2026. These were awarded at a price of $0 per share as part of his compensation.
The award consists of restricted stock units that each convert into one share of common stock. One-third of the RSUs will vest on each of the first three anniversaries of the grant date under Silicon Laboratories’ 2009 Stock Incentive Plan. Following this grant, Conrad directly holds 34,049 shares of Silicon Laboratories common stock.
Johnson Robert Matthew reported acquisition or exercise transactions in a Form 4 filing for SLAB. The filing lists transactions totaling 25,218 shares. Following the reported transactions, holdings were 98,906 shares.
Butler Dean Warren reported acquisition or exercise transactions in a Form 4 filing for SLAB. The filing lists transactions totaling 11,033 shares. Following the reported transactions, holdings were 49,906 shares.
Silicon Laboratories filed its annual report detailing its secure, intelligent wireless IoT chip business and a pending all-cash merger with Texas Instruments at $231.00 per share. If completed, Silicon Labs will become a wholly owned TI subsidiary and its stock will be delisted.
The merger, unanimously approved by the board, is expected to close in the first half of 2027, subject to stockholder and regulatory approvals and customary conditions. In 2025, the company emphasized its fabless model, deep mixed-signal and RF CMOS expertise, and diversified IoT portfolio across industrial, commercial, home, and health applications.
R&D spending was $353.2 million in 2025, or 45.0% of revenue, underscoring a heavy innovation focus. Business is globally oriented, with 91% of 2025 revenue from outside the U.S. and significant reliance on distributors Arrow Electronics and Edom Technology. Human capital and ESG initiatives highlight engineering depth, diversity, and sustainability commitments, while extensive risk disclosures address the merger, supply chain, competition, cybersecurity, trade policy, and geopolitical exposure.
Texas Instruments and Silicon Labs describe a proposed merger under which the two companies plan to combine their businesses, positioning themselves as a global leader in embedded wireless connectivity solutions. The message from TI’s CEO to Silicon Labs employees emphasizes shared culture, engineering focus and career opportunities after the acquisition.
The communication explains that Silicon Labs will file a proxy statement for a special stockholder meeting to seek approval of the proposed transaction, and outlines that completion also depends on Hart‑Scott‑Rodino antitrust clearance and other regulatory and contractual conditions. It also highlights extensive forward‑looking risk factors, including potential deal failure, business disruption, employee retention challenges, litigation, unexpected costs and broader economic and industry pressures such as the global memory chip shortage.
Texas Instruments plans to acquire Silicon Labs in an all-cash deal where Silicon Labs stockholders will receive $231 per share. TI targets more than $450 million in annual manufacturing and operational synergies within three years after close and expects the deal to be accretive to earnings per share, excluding transaction-related costs, in the first full year post-close. TI intends to fund the acquisition with cash on hand and about $7 billion of new debt while maintaining its strategy of returning 100% of free cash flow to shareholders through dividends and buybacks. Management expects approximately 75% of Silicon Labs’ 2030 revenue to be produced inside TI’s manufacturing footprint, leveraging its 300mm fabs and 28nm mixed-signal process. Closing is expected in the first half of 2027, subject to Silicon Labs stockholder approval and regulatory clearances in multiple countries, including China.
Texas Instruments Incorporated has signed a definitive agreement to acquire Silicon Labs, aiming to create a global leader in embedded wireless connectivity. The companies expect the transaction to close in the first half of 2027, subject to required regulatory approvals and other customary closing conditions.
Until closing, Texas Instruments and Silicon Labs will operate independently, and suppliers are instructed to keep working with their existing contacts. Silicon Labs plans to file a proxy statement so its stockholders can vote on the deal, and investors are directed to SEC filings for detailed information and risks, including antitrust review, possible delays, and business impacts if the merger is not completed.